z-logo
open-access-imgOpen Access
Lycopene and Apo-10′-lycopenoic Acid Have Differential Mechanisms of Protection against Hepatic Steatosis in β-Carotene-9′,10′-oxygenase Knockout Male Mice
Author(s) -
Blanche C. Ip,
Liu Chun,
Alice H. Lichtenstein,
Johannes von Lintig,
Xiang-Dong Wang
Publication year - 2014
Publication title -
journal of nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.463
H-Index - 265
eISSN - 1541-6100
pISSN - 0022-3166
DOI - 10.3945/jn.114.200238
Subject(s) - steatosis , medicine , endocrinology , fatty liver , fatty acid synthase , liver x receptor , nonalcoholic fatty liver disease , lycopene , biology , chemistry , biochemistry , lipid metabolism , carotenoid , nuclear receptor , transcription factor , gene , disease
Nonalcoholic fatty liver disease is positively associated with obesity and cardiovascular disease risk. Apo-10'-lycopenoic acid (APO10LA), a potential oxidation product of apo-10'-lycopenal that is generated endogenously by β-carotene-9',10'-oxygenase (BCO2) cleavage of lycopene, inhibited hepatic steatosis in BCO2-expressing mice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom